Musculoskeletal Cancers Remote Monitoring and Care

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

NCT Number	NCT07129226
Lead Sponsor	Case Comprehensive Cancer Center
Conditions	Osteosarcoma, Metastatic Bone Disease
Enrollment	60 participants
Start Date	2026-02-12
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-06